Genmab — November 2018
-
Lad os håbe det er opladning til ASH.
-
Det er da dobbeltmoral så det basker ,, først nedjustere og så skovle ind ... CITY
-
Så kunne næste uge måske blive spændende...?
-
De har ikke rent mel i posen
-
That´s BIG BUSINESS!!
-
Banditter i habitter
-
That´s the name of the game...os små investorer er bare usandsynlig bittesmå brikker i det store spil.
-
Mon finanstilsynet kunne tage sig sammen og kigge på det..
-
God morgen.
-
God morgen
-
The case is currently in pre-trial discovery, and a jury trial is scheduled to start in February 2019. The currently litigated patents are US 8,263,746, US 9,200,061 and US 9,758,590. In addition, Janssen, Genmab, Sanofi and Takeda opposed a European counterpart of the litigated U.S. patents, EP2511297. The patent was revoked in opposition proceedings. We appealed and the proceedings are currently pending.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind